Skip to main content

Principles of Clinical Toxicology Certificate Program (2026-2028)

Tracking # 20-1351306

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

This program was developed for laboratory professionals at all levels who work in labs that perform toxicology testing, as well as other health care professionals with an interest in this specialty. The content will provide participants with a basic background in clinical toxicology, cover most screening procedures, illustrate best practices, and show how toxicology testing shapes diagnosis and treatment decisions. This program was developed in cooperation with the Therapeutic Drug Management and Toxicology Division.

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

10h Category 1

Molecular Diagnostics Diplomate

10h Category 1

Toxicological Chemistry Diplomate

10h Category 1

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

10h General (Clinical Chemistry/UA/Toxicology)

Clinical Laboratory Supervisor

10h General (Clinical Chemistry/UA/Toxicology)

Clinical Laboratory Technician

10h General (Clinical Chemistry/UA/Toxicology)

Clinical Laboratory Technologist

10h General (Clinical Chemistry/UA/Toxicology)

Public Health Director

10h General (Clinical Chemistry/UA/Toxicology)

Public Health Supervisor

10h General (Clinical Chemistry/UA/Toxicology)

Public Health Technologist

10h General (Clinical Chemistry/UA/Toxicology)

Disclosure statements

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.


The following planners and faculty reported relevant financial relationship(s), and have indicated that those relationships would not impact the content of the activity:

  • Jill Warrington, MD, PhD
  • Stocks/Bonds: Aspenti Health
  • Andrea Terrell, PhD, DABCC
  • Salary/Consulting fees: AIT Laboratories


The following planners and faculty reported no relevant financial relationships:

  • Kamisha Johnson-Davis, PhD, DABCC
  • Stacy E.F. Melanson, MD, PhD
  • He Sarina Yang, PhD, DABCC
  • Joshua Akin, MAS, MLS
  • James Ritchie, PhD, FADLM, DABCC
  • Jaime Noguez, PhD, DABCC